Your Location:
Home >
Browse articles >
Mechanism of Shugan Huazheng Prescription Against Liver Fibrosis Based on HIF-1α /VEGF/TGF-β 1 Pathway
Mechanism of Shugan Huazheng Prescription Against Liver Fibrosis Based on HIF-1
α /VEGF/TGF-β 1 Pathway- “The latest research has found that the Shu Gan Hua formula can effectively treat liver fibrosis induced by carbon tetrachloride, possibly by regulating the HIF-1 α/VEGF/TGF - β 1 signaling pathway.”
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 30, Issue 8, Pages: 57-65(2024)
DOI: 10.13422/j.cnki.syfjx.20232140
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 3 ) Tabs( 5 )
References
Publication Info
Metrics
364
Views
184
Downloads
2
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Effect of Artesunate on Experimental Choroidal Neovascularization and Expression of HIF-1α and VEGF
Sini San Treats Liver Fibrosis by Regulating Polarization of Intrahepatic Kupffer Cells
Effect of Yinqi Sanhuang Jiedu Decoction on Piezo1-YAP Signaling Axis and Macrophage Polarization in Mouse Model of Liver Fibrosis
Modified Taohe Chengqitang Regulates Notch/eNOS Signaling Pathway to Inhibit Hepatic Sinusoidal Capillarization
Regulatory Effect and Mechanisms of Liuhuang Zhike Prescription on Glycemic Control in db/db Mice via AMPK/Akt/GSK-3β Signaling Pathway
Related Author
XING Anli
ZHAO Kunpeng
ZHANG Qiuju
LI Jiena
CHEN Shiyu
GUO Jiaqi
ZHANG Ming
Jia-xian LI
Related Institution
Clinical College, Gansu University of Chinese Medicine
Eye Hospital, China Academy of Chinese Medical Sciences
College of Pharmacy, Nanjing University of Chinese Medicine
Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine
Guang'anmen Hospital, China Academy of Chinese Medical Sciences


